EVEROLIMUS MSDS PDF

Acute toxicity: oral toxicity (LD50): > mg/kg (mouse), > mg/kg (rat) – toxicity data from the Abbott Vascular MSDS dated January 16, for Everolimus. SAFETY DATA SHEET. (in accordance with Regulation (EU) /). Everolimus. Version: 1. Revision date: 29/06/ Page 1 of. Material Safety Data Sheet. Section 1 – Product and Company Information. Product Name: Everolimus. Cat. Code: tlrl-eve. Company identification: InvivoGen.

Author: Dukree Shakazuru
Country: Cayman Islands
Language: English (Spanish)
Genre: History
Published (Last): 1 November 2014
Pages: 120
PDF File Size: 12.27 Mb
ePub File Size: 1.32 Mb
ISBN: 183-2-76134-494-5
Downloads: 68665
Price: Free* [*Free Regsitration Required]
Uploader: Nikokus

Omeprazole The serum concentration of Everolimus can be increased when it is combined with Omeprazole. Deflazacort The metabolism of Everolimus can be decreased when combined with Deflazacort. Lepirudin The risk or severity of bleeding can ,sds increased when Lepirudin is combined with Everolimus. Elvitegravir The metabolism of Everolimus can be decreased when combined with Elvitegravir. Aldosterone The metabolism of Everolimus can be decreased when combined with Aldosterone.

Antilymphocyte immunoglobulin everolimjs The risk or severity of adverse effects can be increased when Everolimus is combined with Antilymphocyte immunoglobulin horse. Dirithromycin The metabolism of Everolimus can be decreased when combined with Dirithromycin.

Interferon gamma-1b The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Everolimus. Human adenovirus e serotype 4 strain cl antigen The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl antigen is combined with Everolimus.

Bufylline The metabolism of Bufylline can be everolmus when combined with Jsds. Cephalexin The metabolism of Everolimus can be decreased when combined with Cephalexin. Grapiprant The serum concentration of Grapiprant can be increased when it is combined with Everolimus. Apremilast The metabolism of Everolimus can be decreased when combined with Apremilast. Nicergoline The serum concentration of Nicergoline can be increased when it is combined with Everolimus. Ketazolam The msxs of Everolimus can be decreased when combined with Ketazolam.

  DRETSKE CONCLUSIVE REASONS PDF

Everolimus – DrugBank

Astaxanthin The risk or severity of bleeding can be increased when Astaxanthin is combined with Everolimus. No account, fast registration. Omarigliptin The therapeutic efficacy of Omarigliptin can be decreased when used in combination with Everolimus. Dihydroergocornine The metabolism of Everolimus can be decreased when combined with Dihydroergocornine. Estriol The serum concentration of Estriol can be increased when it is combined with Everolimus.

Parecoxib The metabolism of Everolimus can be decreased when combined with Parecoxib. Idarubicin The risk or severity of adverse effects can be increased when Idarubicin is combined with Everolimus. Lisofylline The metabolism of Lisofylline can be decreased when combined with Everolimus.

Everolimus

Cyclopenthiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Everolimus. Oxaliplatin The risk or severity of adverse effects eevrolimus be increased when Oxaliplatin is combined with Everolimus.

Ivabradine The metabolism of Everolimus can be decreased when combined with Ivabradine. Clostridium tetani toxoid antigen formaldehyde inactivated The everolimjs efficacy of Clostridium tetani toxoid antigen formaldehyde inactivated can be decreased when used in combination with Everolimus. Lorvotuzumab mertansine The metabolism of Everolimus can be decreased when combined with Lorvotuzumab mertansine.

Bivalirudin The risk or severity of bleeding can be increased when Bivalirudin is combined with Everolimus. Idraparinux The risk or severity of bleeding can be increased when Idraparinux is combined with Everolimus. Itraconazole The serum concentration of Everolimus can be increased when it is combined with Itraconazole. Halofantrine The metabolism of Everolimus can be decreased when combined with Halofantrine. Fosamprenavir The metabolism ,sds Everolimus can be decreased when combined with Fosamprenavir.

  ALDUS SPRAK ZARATHUSTRA PDF

Avasimibe The metabolism of Everolimus can be increased when combined with Avasimibe. Etoposide The serum concentration of Everolimus can be increased when it is combined with Etoposide. Aprobarbital The metabolism of Everolimus can be increased when combined with Aprobarbital.

Glibornuride The therapeutic efficacy mss Glibornuride can be decreased when used in combination with Everolimus. Estrone sulfate The metabolism of Everolimus can be decreased when combined with Estrone sulfate. Hydrocodone The metabolism of Everolimus can be decreased when combined with Hydrocodone. Oxymorphone The metabolism of Everolimus can be decreased when combined with Oxymorphone.

Moexiprilat The risk or severity of adverse effects can be increased when Everolimus is combined with Moexiprilat. SKIN Wear appropriate protective gloves and clothing to prevent skin exposure.

Eevrolimus The metabolism of Everolimus can be decreased when combined with Bisoprolol. Clopidogrel The metabolism of Everolimus can be decreased when combined with Clopidogrel.

Everolimus Targets 1 Enzymes 1 Transporters 3 Biointeractions 5. Gramicidin D The serum concentration of Everolimus can be increased when it is combined with Gramicidin D. Acarbose The therapeutic efficacy of Acarbose can be decreased when used in combination with Everolimus.

Abciximab The risk or severity of bleeding can be increased when Abciximab is combined with Everolimus. Obinutuzumab The risk or severity of adverse effects can be increased when Everolimus is combined with Obinutuzumab. Fluperolone The risk or severity of adverse effects can be increased when Everolimus is combined with Fluperolone.

Methysergide The metabolism of Everolimus can be decreased when combined with Methysergide. Carboxyamidotriazole The metabolism of Everolimus can be decreased when combined with Carboxyamidotriazole.